Upgrade to SI Premium - Free Trial

Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs

May 31, 2017 5:12 AM
Goldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.Analyst Jami Rubin writes to clients in a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Hot Comments

Next Articles